Cytokinetics Inc (CYTK)
51.33
-1.54
(-2.91%)
USD |
NASDAQ |
Jun 26, 14:37
Cytokinetics Excess Tax Benefit from Stock Compensation (Quarterly)
Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Excess Tax Benefit from Stock Compensation (Quarterly) Data
Date | Value |
---|---|
December 31, 2009 | -- |
Date | Value |
---|---|
September 30, 2009 | -- |
Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Amgen Inc | -- |
Eli Lilly and Co | -- |
Gilead Sciences Inc | -- |
Insmed Inc | -- |
Avinger Inc | -- |